DAVID J. MACK - 30 Apr 2025 Form 4 Insider Report for BioXcel Therapeutics, Inc. (BTAI)

Role: Director
Signature: /s/ Richard Steinhart, Attorney-in-Fact for David J. Mack
Issuer symbol: BTAI
Transactions as of: 30 Apr 2025
Net transactions value: $0
Form type: 4
Filing time: 01 May 2025, 19:23:09 UTC
Previous filing: 01 Apr 2025
Next filing: 02 Jun 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BTAI	Common Stock	Options Exercise		+1,693	+20%		10,158	30 Apr 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BTAI	Restricted Stock Units	Options Exercise	$0	-1,693	-14%	$0.000000	10,159	30 Apr 2025	Common Stock	1,693		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
F2	On November 21, 2024, the Reporting Person was granted 20,317 RSUs, vesting in twelve equal installments on the last date of each month beginning on November 30, 2024, subject to his continued service as a Director through the vesting period.